<?xml version="1.0" encoding="UTF-8"?>
<ref id="hep41480-bib-0054">
 <label>54</label>
 <mixed-citation publication-type="journal" id="hep41480-cit-0054">
  <string-name>
   <surname>Agarwal</surname>
   <given-names>K</given-names>
  </string-name>, 
  <string-name>
   <surname>Brunetto</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Seto</surname>
   <given-names>WK</given-names>
  </string-name>, 
  <string-name>
   <surname>Lim</surname>
   <given-names>Y‐S</given-names>
  </string-name>, 
  <string-name>
   <surname>Fung</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Marcellin</surname>
   <given-names>P</given-names>
  </string-name>, et al. 
  <article-title>96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection</article-title>. 
  <source xml:lang="en">J Hepatol</source>
  <year>2018</year>;
  <volume>68</volume>:
  <fpage>672</fpage>‐
  <lpage>681</lpage>.
  <pub-id pub-id-type="pmid">29756595</pub-id>
 </mixed-citation>
</ref>
